Literature DB >> 19520168

In vivo micro-CT imaging of liver lesions in small animal models.

Lucia Martiniova1, Daniel Schimel, Edwin W Lai, Andrea Limpuangthip, Richard Kvetnansky, Karel Pacak.   

Abstract

Three-dimensional micro computed tomography (microCT) offers the opportunity to capture images liver structures and lesions in mice with a high spatial resolution. Non-invasive microCT allows for accurate calculation of vessel tortuosity and density, as well as liver lesion volume and distribution. Longitudinal monitoring of liver lesions is also possible. However, distinguishing liver lesions from variations within a normal liver is impossible by microCT without the use of liver- or tumor-specific contrast-enhancing agents. The combination of microCT for morphologic imaging with functional imaging, such as positron emission tomography (PET) or single photon emission tomography (SPECT), offers the opportunity for better abdominal imaging and assessment of structure discrepancies visible by functional imaging. This paper describes methods of current microCT imaging options for imaging of liver lesions compared to other imaging techniques in small animals. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520168      PMCID: PMC2818035          DOI: 10.1016/j.ymeth.2009.05.016

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  29 in total

Review 1.  High resolution X-ray computed tomography: an emerging tool for small animal cancer research.

Authors:  M J Paulus; S S Gleason; S J Kennel; P R Hunsicker; D K Johnson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  In vivo respiratory-gated micro-CT imaging in small-animal oncology models.

Authors:  Dawn Cavanaugh; Evan Johnson; Roger E Price; Jonathan Kurie; Elizabeth L Travis; Dianna D Cody
Journal:  Mol Imaging       Date:  2004-01       Impact factor: 4.488

3.  Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner.

Authors:  Nancy L Ford; Kevin C Graham; Alan C Groom; Ian C Macdonald; Ann F Chambers; David W Holdsworth
Journal:  Invest Radiol       Date:  2006-04       Impact factor: 6.016

Review 4.  In vivo imaging in experimental preclinical tumor research--a review.

Authors:  J T Wessels; A C Busse; J Mahrt; C Dullin; E Grabbe; G A Mueller
Journal:  Cytometry A       Date:  2007-08       Impact factor: 4.355

5.  Imaging techniques for small animal imaging models of pulmonary disease: micro-CT.

Authors:  Kennita A Johnson
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

6.  MicroCT liver contrast agent enhancement over time, dose, and mouse strain.

Authors:  Chris E Suckow; David B Stout
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

7.  Micro-CT imaging with a hepatocyte-selective contrast agent for detecting liver metastasis in living mice.

Authors:  Hye Won Kim; Quan-Yu Cai; Hong Yeoung Jun; Kwon Su Chon; Seung Hoon Park; Seung Jae Byun; Myung Soo Lee; Jae Min Oh; Hun Soo Kim; Kwon-Ha Yoon
Journal:  Acad Radiol       Date:  2008-10       Impact factor: 3.173

Review 8.  [A case of malignant pheochromocytoma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD). A review of the Japanese literature of malignant pheochromocytoma treated with a combination of CVD].

Authors:  O Mizuno
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1994-11-20

9.  Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.

Authors:  Suh-Chin J Lin; Kuo-Fen Lee; Alexander Yu Nikitin; Susan G Hilsenbeck; Robert D Cardiff; Aihua Li; Keon-Wook Kang; Steven A Frank; Wen-Hwa Lee; Eva Y-H P Lee
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

10.  Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.

Authors:  Lucia Martiniova; Edwin W Lai; Abdel G Elkahloun; Mones Abu-Asab; Andrea Wickremasinghe; Daniel C Solis; Shiromi M Perera; Thanh-Truc Huynh; Irina A Lubensky; Arthur S Tischler; Richard Kvetnansky; Salvatore Alesci; John C Morris; Karel Pacak
Journal:  Clin Exp Metastasis       Date:  2009-01-25       Impact factor: 5.150

View more
  19 in total

1.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Authors:  Ketan B Ghaghada; Cristian T Badea; Lohitash Karumbaiah; Nicole Fettig; Ravi V Bellamkonda; G A Johnson; Ananth Annapragada
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

2.  Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Authors:  Lucia Martiniova; Shiromi M Perera; Frederieke M Brouwers; Salvatore Alesci; Mones Abu-Asab; Amanda F Marvelle; Dale O Kiesewetter; David Thomasson; John C Morris; Richard Kvetnansky; Arthur S Tischler; James C Reynolds; Antonio Tito Fojo; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

Review 3.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

4.  In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.

Authors:  Kathleen Gabrielson; Robert Maronpot; Sébastien Monette; Coraline Mlynarczyk; Yuval Ramot; Abraham Nyska; Polina Sysa-Shah
Journal:  ILAR J       Date:  2018-12-01

5.  Contrast-enhanced micro-computed tomography using ExiTron nano6000 for assessment of liver injury.

Authors:  Xiang-Wei Hua; Tian-Fei Lu; Da-Wei Li; Wei-Gang Wang; Jun Li; Zhen-Ze Liu; Wei-Wei Lin; Jian-Jun Zhang; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 6.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

7.  Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats.

Authors:  Cherif Akladios; Mihaela Ignat; Didier Mutter; Marc Aprahamian
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

8.  The utility of micro-CT and MRI in the assessment of longitudinal growth of liver metastases in a preclinical model of colon carcinoma.

Authors:  Prachi Pandit; Samuel M Johnston; Yi Qi; Jennifer Story; Rendon Nelson; G Allan Johnson
Journal:  Acad Radiol       Date:  2013-04       Impact factor: 3.173

Review 9.  Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?

Authors:  Esther Korpershoek; Karel Pacak; Lucia Martiniova
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

Review 10.  In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast.

Authors:  Connor A Wathen; Nathan Foje; Tony van Avermaete; Bernadette Miramontes; Sarah E Chapaman; Todd A Sasser; Raghuraman Kannan; Steven Gerstler; W Matthew Leevy
Journal:  Sensors (Basel)       Date:  2013-05-27       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.